PABAX
Price
$17.40
Change
-$0.03 (-0.17%)
Updated
Oct 20 closing price
Net Assets
2.33B
RLBCX
Price
$39.01
Change
+$0.26 (+0.67%)
Updated
Oct 20 closing price
Net Assets
265.62B
Interact to see
Advertisement

PABAX vs RLBCX

Header iconPABAX vs RLBCX Comparison
Open Charts PABAX vs RLBCXBanner chart's image
Putnam Dynamic Asset Allocation Bal A
Price$17.40
Change-$0.03 (-0.17%)
VolumeN/A
Net Assets2.33B
American Funds American Balanced R3
Price$39.01
Change+$0.26 (+0.67%)
VolumeN/A
Net Assets265.62B
PABAX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
PABAX vs. RLBCX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABAX is a Hold and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 266B vs. PABAX (2.33B). PABAX pays higher dividends than RLBCX: PABAX (2.46) vs RLBCX (1.49). PABAX was incepted earlier than RLBCX: PABAX (32 years) vs RLBCX (23 years). PABAX (0.93) and RLBCX (0.89) have similar cost to investors . PABAX is a more actively managed with annual turnover of: 222.00 vs. RLBCX (44.00). PABAX has a lower initial minimum investment than RLBCX: PABAX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 9.01 vs. PABAX (2.05). RLBCX return over 5 years is better than : 42.54 vs. PABAX (21.96).
PABAXRLBCXPABAX / RLBCX
Total Expense Ratio0.930.89104%
Annual Report Gross Expense Ratio0.930.89104%
Fund Existence32 years23 years-
Gain YTD11.96115.13279%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.33B266B1%
Annual Yield % from dividends2.461.49165%
Returns for 1 year2.059.0123%
Returns for 3 years36.9949.6675%
Returns for 5 years21.9642.5452%
Returns for 10 years39.6370.2856%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP1.470.07
+5.00%
PMV Pharmaceuticals
OWL16.680.50
+3.09%
Blue Owl Capital
AROW26.820.68
+2.60%
Arrow Financial Corp
LFST5.160.12
+2.38%
LifeStance Health Group
JFBR3.740.05
+1.36%
Jeffs Brands Ltd